A critical breakthrough in cancer study is arising with the use of mini-antibodies to reactivate dysfunctional p53. This vital cancer protector protein is frequently disabled in various kinds of malignancies, leading https://bookmarkcitizen.com/story21928872/mini-antibodies-restore-p53-a-promising-pathway-for-malignant-therapy